Skip to main content
. 2022 Jun 26;2022:5848823. doi: 10.1155/2022/5848823

Table 1.

Oncomine analysis of LRRC19 mRNA expression in colorectal cancer.

Cohort no. Cohort Microarray Sample (n) Fold change P value
1 Hong colorectal mRNA Colorectal carcinoma vs. normal −12.606 1.87E − 32

2 Skrzypczak colorectal 2 mRNA Colon carcinoma epithelia vs. normal −4.523 5.01E − 11
mRNA Colon adenoma epithelia vs. normal −3.598 5.64E − 09
mRNA Colon carcinoma vs. normal −5.626 1.02E − 08
mRNA Colon adenoma vs. normal −6.367 8.55E − 07

3 Kaiser colon mRNA Colon mucinous adenocarcinoma vs. normal −10.541 3.22E − 08
mRNA Cecum adenocarcinoma vs. normal −5.335 8.25E − 08
mRNA Colon adenocarcinoma vs. normal −4.466 5.5E − 10
mRNA Rectal adenocarcinoma vs. normal −5.807 0.0000303
mRNA Rectosigmoid adenocarcinoma vs. normal −6.676 0.0000224

4 Gaedeke colorectal mRNA Rectal adenocarcinoma vs. normal −7.798 3.04E − 35

5 Skrzypczak colorectal mRNA Colorectal adenocarcinoma vs. normal −2.757 3.71E − 14
mRNA Colorectal carcinoma vs. normal −4.481 1.74E − 10

6 Sabates–Bellver colon mRNA Colon adenoma vs. normal −2.58 5.24E − 13
mRNA Rectal adenoma vs. normal −2.955 0.000167

7 TCGA colorectal mRNA Colon mucinous adenocarcinoma vs. normal −11.699 2.11E − 13
mRNA Rectal adenocarcinoma vs. normal −7.875 8.12E − 15
mRNA Cecum adenocarcinoma vs. normal −8.857 4.47E − 10
mRNA Colon adenocarcinoma vs. normal −6.529 3.42E − 13